| Year |
Citation |
Score |
| 2020 |
Ren H, Bakas NA, Vamos M, Chaikuad A, Limpert AS, Wimer CD, Brun SN, Lambert LJ, Tautz L, Celeridad M, Sheffler DJ, Knapp S, Shaw RJ, Cosford NDP. Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. PMID 33200929 DOI: 10.1021/acs.jmedchem.0c00873 |
0.065 |
|
| 2017 |
Finlay D, Teriete P, Vamos M, Cosford NDP, Vuori K. Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins. F1000research. 6: 587. PMID 28529715 DOI: 10.12688/f1000research.10625.1 |
0.018 |
|
| 2015 |
Pache L, Dutra MS, Spivak AM, Marlett JM, Murry JP, Hwang Y, Maestre AM, Manganaro L, Vamos M, Teriete P, Martins LJ, König R, Simon V, Bosque A, Fernandez-Sesma A, et al. BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency. Cell Host & Microbe. 18: 345-53. PMID 26355217 DOI: 10.1016/J.Chom.2015.08.009 |
0.01 |
|
| 2015 |
Egan DF, Chun MG, Vamos M, Zou H, Rong J, Miller CJ, Lou HJ, Raveendra-Panickar D, Yang CC, Sheffler DJ, Teriete P, Asara JM, Turk BE, Cosford ND, Shaw RJ. Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates. Molecular Cell. PMID 26118643 DOI: 10.1016/J.Molcel.2015.05.031 |
0.04 |
|
| 2014 |
Vamos M, Cosford ND. 2-Aminopyridines via reaction of pyridine N-oxides and activated isocyanides. The Journal of Organic Chemistry. 79: 2274-80. PMID 24490824 DOI: 10.1021/jo402693s |
0.354 |
|
| 2014 |
Finlay D, Vamos M, González-López M, Ardecky RJ, Ganji SR, Yuan H, Su Y, Cooley TR, Hauser CT, Welsh K, Reed JC, Cosford ND, Vuori K. Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: roles of XIAP and cIAPs. Molecular Cancer Therapeutics. 13: 5-15. PMID 24194568 DOI: 10.1158/1535-7163.MCT-13-0153 |
0.043 |
|
| 2013 |
Vamos M, Welsh K, Finlay D, Lee PS, Mace PD, Snipas SJ, Gonzalez ML, Ganji SR, Ardecky RJ, Riedl SJ, Salvesen GS, Vuori K, Reed JC, Cosford ND. Expedient synthesis of highly potent antagonists of inhibitor of apoptosis proteins (IAPs) with unique selectivity for ML-IAP. Acs Chemical Biology. 8: 725-32. PMID 23323685 DOI: 10.1021/Cb3005512 |
0.125 |
|
| 2012 |
Sheffler DJ, Wenthur CJ, Bruner JA, Carrington SJ, Vinson PN, Gogi KK, Blobaum AL, Morrison RD, Vamos M, Cosford ND, Stauffer SR, Daniels JS, Niswender CM, Conn PJ, Lindsley CW. Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAM. Bioorganic & Medicinal Chemistry Letters. 22: 3921-5. PMID 22607673 DOI: 10.1016/J.Bmcl.2012.04.112 |
0.062 |
|
| 2009 |
Vamos M, Kobayashi Y. Propellane as a conformational device for the stabilization of the β-lactone of salinosporamide A Tetrahedron. 65: 5899-5903. DOI: 10.1016/J.Tet.2009.05.085 |
0.464 |
|
| 2008 |
Vamos M, Kobayashi Y. Scalable preparation of both enantiomers of 2-(1-hydroxy-2-oxocyclohexyl)acetic acid. The Journal of Organic Chemistry. 73: 3938-41. PMID 18416575 DOI: 10.1021/Jo8000904 |
0.457 |
|
| 2007 |
Vamos M, Ozboya K, Kobayashi Y. Synthesis of bicyclic pyroglutamic acid featuring the ugi reaction and a unique stereoisomerization at the angular position by Grob fragmentation followed by a transannular ketene [2+2] cycloaddition reaction Synlett. 1595-1599. DOI: 10.1055/S-2007-982538 |
0.464 |
|
| Show low-probability matches. |